Does Ozempic Cause Hair Loss?
Summary: Hair shedding on semaglutide is real but indirect. The STEP-1 trial saw it in about 3% of Wegovy patients versus 1% on placebo, the cause is telogen effluvium from rapid weight loss, and hair regrows 6 to 12 months after weight stabilizes.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
The short answer: yes, some people lose hair on Ozempic, but the drug is not the direct cause. In the STEP-1 trial of semaglutide 2.4 mg (the Wegovy dose), about 3% of patients reported hair loss versus 1% on placebo [1]. The mechanism is telogen effluvium, a stress response to rapid weight loss, and it is reversible. Hair regrows on its own once weight stabilizes, typically over 6 to 12 months.
Below is what the trial data actually shows, how telogen effluvium works, why women report it more often, and what to do if you start finding hair on your pillow.
What the clinical trials show
Hair loss is not listed as a common adverse reaction on the Ozempic label for type 2 diabetes [3]. At the diabetes doses of 0.5, 1.0, and 2.0 mg per week, hair shedding did not separate from placebo in the SUSTAIN trial program. That changed at higher doses.
The Wegovy label, which covers semaglutide 2.4 mg for weight management, lists alopecia (the medical term for hair loss) as an adverse reaction observed at a higher rate than placebo [2]. The pivotal STEP-1 trial published in NEJM reported hair loss in roughly 3% of the semaglutide group compared with about 1% in placebo [1]. That is a real signal, but a small one. Roughly 97 out of 100 patients did not report it.
| Trial population | Semaglutide hair loss rate | Placebo rate |
|---|---|---|
| STEP-1 (Wegovy 2.4 mg, adults with obesity) | ~3% | ~1% |
| SUSTAIN program (Ozempic up to 1 mg, type 2 diabetes) | Not significantly above placebo | Baseline |
The dose-response pattern is the clue. Higher doses produce faster, larger weight loss. Larger weight loss produces more telogen effluvium. The drug molecule itself does not bind to hair follicles or interfere with the keratin pathway. Weight loss is the variable doing the work.
How telogen effluvium actually works
Your scalp hair cycles through three phases. About 80 to 90% of follicles sit in the growth (anagen) phase at any time. A small fraction is in the resting (telogen) phase. When the body experiences a significant stressor, more follicles shift prematurely from anagen into telogen [5]. About two to three months later, those resting hairs shed all at once. The result is diffuse thinning across the entire scalp, not bald patches.
Common triggers for telogen effluvium include childbirth, high fevers, major surgery, severe illness, crash dieting, and bariatric surgery. Rapid weight loss from any cause sits squarely in that list. Losing 15 to 20% of body weight in a year, which is what STEP-1 patients averaged on Wegovy 2.4 mg, is exactly the kind of metabolic shift the follicle stress response was designed to detect.
The defining feature of telogen effluvium is that it is self-limiting. Once the stressor resolves, follicles return to anagen, and the lost hair grows back. The catch is that hair grows at roughly half an inch per month. Visible regrowth takes time even after the shedding stops.
Timeline: when shedding starts and when it stops
The full hair loss arc on a GLP-1 looks like this:
- Months 0 to 2: Weight loss begins. No visible hair changes yet. Follicles are silently shifting into telogen.
- Months 3 to 6: Shedding begins. Patients notice more hair in the shower drain, on the pillow, and in the brush. This is the peak shedding window.
- Months 6 to 12: Shedding continues at a slower rate as weight loss continues. Total hair volume may look noticeably thinner.
- Weight stabilization: Once the scale stops dropping and stays stable for a few weeks, follicles begin shifting back into anagen.
- 6 to 12 months after weight stabilizes: New growth becomes visible. Most patients see full restoration of hair volume within 12 to 18 months of weight plateau.
That last point is the one most people miss. As long as you are still actively losing weight, the stressor is still active. Hair shedding can persist throughout the weight loss phase. The reset begins when weight stops moving.
Why women report it more than men
Anecdotal and survey data consistently show women report hair shedding on GLP-1s at higher rates than men. There are several reasons.
Women lose weight on Wegovy at slightly higher percentages than men in pooled trial data. Women are more likely to enter treatment with marginal iron and ferritin stores, especially women who menstruate. Iron deficiency is one of the most common drivers of hair shedding independent of any drug. Women also notice diffuse thinning earlier because the typical female hair pattern (longer, fuller styles, often dyed or chemically treated) makes a 20 to 30% shedding spike more visually obvious than the same loss on shorter male hair.
The biology is not sex-specific. Telogen effluvium hits both sexes. Reporting is.
Prevention: the four interventions that actually help
You cannot fully prevent telogen effluvium during rapid weight loss. You can reduce its severity. Four interventions matter.
1. Slow the titration
The Wegovy label uses a 16-week titration from 0.25 mg up to 2.4 mg [2]. That schedule is conservative because Novo Nordisk knows GI side effects (and indirectly, hair loss) track with how fast the dose climbs. Patients who feel pressure to escalate faster, or who restart at higher doses after a pause without re-titrating, drive sharper weight loss curves and steeper hair shedding.
If you are noticing significant shedding, talk to your prescriber about staying at your current dose longer before stepping up. A slower weight loss trajectory keeps the body in a smaller stress window. The total weight loss endpoint at 18 months is similar; the shedding intensity in months 3 to 9 can be meaningfully reduced.
2. Hit your protein target
The single most important nutrition intervention is protein. Aim for 1.0 to 1.6 g of protein per kg of body weight per day during active weight loss. A 75 kg adult should consume 75 to 120 g of protein daily. People on GLP-1s often miss this target because appetite suppression cuts total food intake, and protein-dense foods sit heavy in a slow-emptying stomach.
Practical tactics: eat protein first at every meal, build meals around a 25 to 40 g protein anchor (eggs, Greek yogurt, chicken, fish, tofu, whey or plant protein shake), and treat carbs and fats as supplements to that anchor rather than the centerpiece. Protein supports keratin synthesis in the follicle directly, and adequate protein during weight loss also preserves lean muscle mass, which has its own benefits.
3. Check the labs that actually matter
Ask your prescriber to order these at baseline and again at 3 to 6 months on therapy:
- Ferritin (the iron storage marker, more sensitive than serum iron for hair-relevant deficiency; target above 50 to 70 ng/mL for hair growth)
- Vitamin B12
- Vitamin D, 25-OH
- Zinc
- TSH (thyroid; both hypo and hyperthyroidism cause hair loss)
- CBC (general anemia screen)
If any of these come back low, supplement to correct the deficiency before assuming the GLP-1 is the cause of your shedding. Iron deficiency anemia and overt hypothyroidism can mimic or amplify telogen effluvium completely independently of the drug.
Biotin is the supplement most often marketed for hair growth. The evidence for biotin in people without an actual biotin deficiency is weak. True biotin deficiency is rare in adults eating any reasonable diet. A standard daily multivitamin covers it. Megadose biotin can interfere with thyroid and troponin lab assays, which is a problem worth avoiding for a supplement that probably is not helping anyway.
4. Hydrate and sleep
Dehydration is a documented side effect of GLP-1 therapy as nausea and reduced thirst sensation cut fluid intake. Chronic mild dehydration is bad for everything, including the scalp. Aim for clear or pale yellow urine.
Sleep is the second free intervention nobody bothers with. Follicle stem cell cycling is regulated by circadian rhythm. Chronic sleep restriction is its own stressor, stacking on top of the weight loss stress.
What does not work
Several popular interventions do not have good evidence for telogen effluvium specifically.
- Biotin in people without a true deficiency. No reliable evidence of benefit, and it skews lab assays.
- Collagen peptides for hair. The body breaks them down into amino acids like any other protein. Hitting your overall protein target accomplishes the same thing for less money.
- Switching from Ozempic to a different GLP-1. Wegovy, Mounjaro, and Zepbound all drive rapid weight loss at therapeutic doses. The shedding signal travels with the weight loss, not the molecule. Switching does not solve the underlying stress on the follicles.
- Stopping the medication early. If you discontinue Ozempic before reaching your goal weight, you lose most of the metabolic benefit and most patients regain weight. The hair will recover either way once weight stabilizes. Quitting the drug to save your hair is rarely the right tradeoff.
When to see a doctor
Most GLP-1 hair shedding is self-limiting and does not need medical evaluation beyond the lab panel above. See a dermatologist or your prescriber if:
- Shedding lasts longer than 9 months without slowing.
- You see distinct bald patches or a receding hairline (suggests a different diagnosis).
- The scalp is red, scaly, itchy, or painful.
- You have other systemic symptoms (fatigue, cold intolerance, weight changes outside what the drug explains, menstrual changes).
- Hair regrowth has not started 12 months after weight stabilization.
A dermatologist can perform a hair pull test, examine the scalp under magnification (trichoscopy), and run a more targeted workup. In some cases a scalp biopsy is helpful to distinguish telogen effluvium from early androgenetic alopecia, since the two can coexist and the treatment paths differ.
The honest tradeoff
The Wegovy label lists alopecia at roughly 3% above placebo [2]. That is real, but it sits inside a benefit profile that includes 15 to 17% average body weight loss, meaningful reductions in cardiovascular events, and improvements in blood sugar, blood pressure, sleep apnea severity, and joint pain. For most people the math favors the drug. The shedding is temporary; the cardiometabolic benefits compound.
If hair loss is the reason you are considering quitting, talk to your prescriber first. Slower titration, better nutrition, lab-guided supplementation, and (if needed) low-dose minoxidil will solve the problem for most people without giving up the weight loss.
Common questions about Ozempic and hair loss
- Does Ozempic cause hair loss in women more than men?
- Reported rates are higher in women, mostly because women lose slightly more weight on these drugs, are more likely to have marginal iron stores, and notice diffuse thinning earlier due to hair styling and length.
- Can Ozempic cause hair thinning even at low doses?
- At Ozempic doses for type 2 diabetes (0.5 to 2 mg), hair loss did not significantly separate from placebo. The signal appears mainly at the 2.4 mg Wegovy dose where weight loss is fastest.
- How do I stop hair loss from Ozempic?
- Slow your dose titration, hit 1.0 to 1.6 g protein per kg body weight, check labs for iron, B12, vitamin D, zinc, and thyroid, stay hydrated, and consider low-dose oral or topical minoxidil under a dermatologist's care.
- When does hair grow back after stopping Ozempic?
- Hair regrowth begins once weight stabilizes, not specifically when you stop the drug. Most people see visible recovery within 6 to 12 months of weight plateau, with full restoration by 12 to 18 months.
- Is hair loss on Ozempic permanent?
- No. Telogen effluvium from rapid weight loss is reversible. Follicles are not destroyed, they are just resting. Once the stressor resolves, the growth cycle restarts on its own.
- Does biotin help with Ozempic hair loss?
- Probably not, unless you have an actual biotin deficiency, which is rare. Megadose biotin can interfere with thyroid and cardiac lab tests. A standard multivitamin and adequate dietary protein are the better bets.
- Should I stop Ozempic if my hair is falling out?
- Almost never the right call. The shedding is temporary and resolves on its own. Discontinuing usually means losing your weight loss progress, and the cardiometabolic benefits are large. Talk to your prescriber about slower titration first.
- How much hair loss is normal on Ozempic?
- Trial data show roughly 3% of Wegovy patients report noticeable hair loss versus 1% on placebo. Diffuse thinning across the whole scalp during months 3 to 9 is the typical pattern. Patchy loss is not telogen effluvium and warrants a dermatology visit.
- Will switching from Ozempic to Wegovy or Mounjaro fix the hair loss?
- No. The shedding tracks with weight loss speed, not the specific molecule. All therapeutic-dose GLP-1s and GLP-1/GIP agonists produce similar telogen effluvium risk because they produce similar rapid weight loss.
What this article does not cover
This page focuses on hair shedding from semaglutide. Adjacent topics like skin laxity ("Ozempic face"), muscle loss during weight loss, and specific dermatology workups for non-telogen-effluvium hair conditions have their own pages on this site. If you are seeing patchy loss, scarring, or scalp inflammation, do not self-treat as telogen effluvium. See a board-certified dermatologist.
References
- Wilding JPH et al, Once-Weekly Semaglutide in Adults with Overweight or Obesity, NEJM 2021 (STEP 1)
- FDA Wegovy (semaglutide) prescribing information
- FDA Ozempic (semaglutide) prescribing information
- Cleveland Clinic, Does Ozempic Cause Hair Loss? What We Know
- Phillips T and Slomiany WP, Hair Loss: Common Causes and Treatment, American Family Physician